Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yuka Morikawa-Inomata"'
Autor:
Kazuya Kinoshita, Shibakawa Nobuhiko, Yoshifumi Fujita, Fumi Inaba, Yuka Morikawa-Inomata, Keiichi Tabata, Keiichi Ito, Atsuyuki Tomizawa
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 326:163-170
In the present report, we evaluated the effect of the novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526) and 2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylme
Autor:
Shibakawa Nobuhiko, Keiichi Ito, Fumi Inaba, Yuka Morikawa-Inomata, Keiichi Tabata, Atsuyuki Tomizawa, Kazuya Kinoshita, Naotoshi Yamamura
Publikováno v:
Biologicalpharmaceutical bulletin. 32(12)
In the present study, we evaluated the effect of the novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526) on the intragastric acidity of cynomolgus monkeys. The stu
Autor:
Shibakawa Nobuhiko, Keiichi Tabata, Fumi Inaba, Atsuyuki Tomizawa, Kazuya Kinoshita, Yuka Morikawa-Inomata, Mitsuko Makino, Keiichi Ito
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 323(1)
The pharmacological profiles of the novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methylcyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526) were investigated in terms of hog gastric H+,K+-ATPase activity, gastric ac